ICER
ICER
  • ICER Analytics™
  • Donate
  • Who We Are
    • History & Impact
    • People
    • Independent Funding
    • Frequently Asked Questions (FAQs)
  • Our Approach
    • Methods & Process
    • Policies
  • Engage with ICER
    • Patients
    • Clinicians
    • Manufacturers
    • Prospective Employees
    • Committees & Boards
  • News & Insights
    • Press Releases
    • Commentaries
    • Journal Articles
    • Weekly View
  • Explore Our Research
    • Assessments
    • Policy Papers
    • ICER Calendar
    • ICER ANALYTICS™
USA Today: Critics target institute that evaluates price, value of drugs

USA Today: Critics target institute that evaluates price, value of drugs

A USA Today article examines ICER’s role in the review the price and value of new drugs in the midst of rising drug costs, and explores the reactions of critics to ICER’s work. In a video interview accompanying the article, Dr. Steven Pearson, ICER’s President and Founder, provides added insight into ICER’s work.

http://www.usatoday.com/story/news/politics/2016/07/28/critics-target-institute-evaluates-price-value-drugs/87355212/

Back to Top
  • Contact
  • Careers
  • Find a Report
  • Donate
  • ICER ANALYTICS™ LOGIN

OUR NEWSLETTER.

A weekly digest of the top news
on ICER and US drug pricing. Sign Up


CONTACT US

Institute for Clinical and Economic Review
Two Liberty Square, Ninth Floor, Boston, MA 02109
Get Directions

+1 (617) 528-4013

Email: info@icer.org

Media Inquiries: mediainquiries@icer.org

ICER
© ICER, 2021
  • Terms and Conditions
  • Privacy Policy
Twitter Linkedin